Axim Biotechnologies Inc AXIM:OTCQB

Last Price$0.51NASDAQ Previous Close - as of 3:46PM ET 10/15/19

Today's Change+0.02(3.03%)
Bid (Size)$0.45 (5,000)
Ask (Size)$0.51 (1,000)
Day Low / High$0.45 - 0.52
Volume22.6 K
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

Medical Marijuana Is Undervalued At 3.2x Forward Sales
1:22PM ET 5/28/2019 Seeking Alpha

Company Profile

Business DescriptionAXIM Biotechnologies, Inc. is engaged in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. It also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in New York, NY. View company web site for more details
Address45 Rockefeller Plaza
New York, New York 10111
Phone+1.212.332.1677
Number of Employees6
Recent SEC Filing08/14/201910-Q
Chief Executive Officer & DirectorJohn W. Huemoeller
Chief Financial Officer & SecretaryRobert T. Malasek
Director & Chief Technology OfficerLekhram Changoer
Director, Chief Scientific & Medical OfficerPhilip A. van Damme

Company Highlights

Price Open$0.47
Previous Close$0.50
52 Week Range$0.45 - 2.50
Market Capitalization$32.0 M
Shares Outstanding62.8 M
SectorIndustrial Services
IndustryEnvironmental Services
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.11
Beta vs. S&P 500N/A
Revenue$195.6 K
Net Profit Margin-2,280.08%
Return on Equity108.89%